American Association for Cancer Research

Skip to Main Content

Table 4

Association between diffuse positive Skp2 expression and overall survival in each subgroup of ovarian adenocarcinomas^a

	N	P ^b
Adenocarcinoma	91	0.0035
Clinical stage
Stage I	34	0.2368
Stage II/III/IV	57	0.0038
Histological type
Serous	39	0.0189
Nonserous	52	0.1527
Histological grade
Grade 1	56	0.0094
Grade 2/3	35	0.0149

	N	P ^b
Adenocarcinoma	91	0.0035
Clinical stage
Stage I	34	0.2368
Stage II/III/IV	57	0.0038
Histological type
Serous	39	0.0189
Nonserous	52	0.1527
Histological grade
Grade 1	56	0.0094
Grade 2/3	35	0.0149

^a

A Kaplan-Meier survival curve of ovarian cancer patients was categorized as negative, partial positive vs. diffuse positive Skp2 expression.

^b

Log-rank test.